These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 7437264)

  • 1. Methyl conjugation in uraemia: catechol-O-methyltransferase.
    Pazmiño PA; Weinshilboum RM
    Br J Clin Pharmacol; 1980 Nov; 10(5):509-18. PubMed ID: 7437264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thiol S-methylation in uremia: erythrocyte enzyme activities and plasma inhibitors.
    Pazmiño PA; Sladek SL; Weinshilboum RM
    Clin Pharmacol Ther; 1980 Sep; 28(3):356-67. PubMed ID: 7408396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catechol-o-methyltransferase biochemical genetics: human lymphocyte enzyme.
    Sladek-Chelgren S; Weinshilboum RM
    Biochem Genet; 1981 Dec; 19(11-12):1037-53. PubMed ID: 7337686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microassay of human erythrocyte catechol-O-methyltransferase: removal of inhibitory calcium ion with chelating resin.
    Raymond FA; Weinshilboum RM
    Clin Chim Acta; 1975 Jan; 58(2):185-94. PubMed ID: 235384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dihydroxynitrobenzaldehydes and hydroxymethoxynitrobenzaldehydes: synthesis and biological activity as catechol-O-methyltransferase inhibitors.
    Pérez RA; Fernández-Alvarez E; Nieto O; Piedrafita FJ
    J Med Chem; 1992 Nov; 35(24):4584-8. PubMed ID: 1469689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of human erythrocyte and gastroduodenal catechol-O-methyltransferase activity by nitecapone.
    Schultz E; Tarpila S; Bäckström AC; Gordin A; Nissinen E; Pohto P
    Eur J Clin Pharmacol; 1991; 40(6):577-80. PubMed ID: 1884738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of catechol-O-methyltransferase activity in erythrocytes by high performance liquid chromatography with electrochemical detection.
    Schultz E; Nissinen E; Kaakkola S
    Biomed Chromatogr; 1989 Mar; 3(2):64-7. PubMed ID: 2736320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inheritance of low erythrocyte catechol-o-methyltransferase activity in man.
    Weinshilboum RM; Raymond FA
    Am J Hum Genet; 1977 Mar; 29(2):125-35. PubMed ID: 848488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The part played by catechol-O-methyltransferase in the plasma kinetics of 3,4-dihydroxyphenylglycol and 3,4-dihydroxyphenylalanine in the anaesthetized rabbit.
    Friedgen B; Halbrügge T; Graefe KH
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Feb; 347(2):155-61. PubMed ID: 8474536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of catechol-O-methyltransferase by gossypol: the effect of plasma proteins.
    Tang F; Tsang AY; Lee CP; Wong PY
    Contraception; 1982 Nov; 26(5):515-9. PubMed ID: 7160182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics of the reversible tight-binding inhibition of pig liver catechol-O-methyltransferase by [2-(3,4-dihydroxy-2- nitrophenyl)vinyl]phenyl ketone.
    Pérez RA; Fernández-Alvarez E; Nieto O; Piedrafita FJ
    J Enzyme Inhib; 1994; 8(2):123-31. PubMed ID: 7539072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catechol-O-methyltransferase activity in human erythrocytes: methodological aspects.
    Floderus Y; Sääf J; Ross SB; Wetterberg L
    Ups J Med Sci; 1981; 86(3):309-18. PubMed ID: 7324290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variations in catechol O-methyltransferase activity in rodent tissues: possible role in estrogen carcinogenicity.
    Li SA; Purdy RH; Li JJ
    Carcinogenesis; 1989 Jan; 10(1):63-7. PubMed ID: 2910532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacophore-based virtual screening of catechol-o-methyltransferase (COMT) inhibitors to combat Alzheimer's disease.
    Patel CN; Georrge JJ; Modi KM; Narechania MB; Patel DP; Gonzalez FJ; Pandya HA
    J Biomol Struct Dyn; 2018 Nov; 36(15):3938-3957. PubMed ID: 29281938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enantioselectivity in the methylation of the catecholic phase I metabolites of methylenedioxy designer drugs and their capability to inhibit catechol-O-methyltransferase-catalyzed dopamine 3-methylation.
    Meyer MR; Maurer HH
    Chem Res Toxicol; 2009 Jun; 22(6):1205-11. PubMed ID: 19462939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A semiempirical study on inhibition of catechol O-methyltransferase by substituted catechols.
    Ovaska M; Yliniemelä A
    J Comput Aided Mol Des; 1998 May; 12(3):301-7. PubMed ID: 9749372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of 3',4'-dihydroxy-2-methyl-propriophenone (U-0521) on catechol-O-methyltransferase activity and on DOPA accumulation in rat red blood cells and corpus striatum.
    Reches A; Jiang D; Fahn S
    Biochem Pharmacol; 1982 Nov; 31(21):3415-8. PubMed ID: 7150363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ontogenic aspects of liver and kidney catechol-O-methyltransferase sensitivity to tolcapone.
    Vieira-Coelho MA; Soares-da-Silva P
    Br J Pharmacol; 1996 Feb; 117(3):516-520. PubMed ID: 8821542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral and central inhibitors of catechol-O-methyl transferase: effects on liver and brain COMT activity and L-DOPA metabolism.
    Brannan T; Prikhojan A; Yahr MD
    J Neural Transm (Vienna); 1997; 104(1):77-87. PubMed ID: 9085195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human erythrocyte phenol O-methyltransferase: radiochemical microassay and biochemical properties.
    Pazmiño PA; Weinshilboum RM
    Clin Chim Acta; 1978 Oct; 89(2):317-29. PubMed ID: 709878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.